ClinicalTrials.gg
CompletedNCT07551908Updated Aug 26, 2026

Evaluation of the Effect of the Mouthwash on Delicate Gums

An interventional study of Mouthwash for delicate gums in Gingivitis, sponsored by Lacer S.A.. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by Lacer S.A. (part of Italfarmaco) · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 15 studies in Gingivitis with a site in Spain — 2 open to participants now, 2 under way, none of them phase 3. Gingivitis · Spain.

Enrollment
9th of 13
33 · median 60
Started
2026
with 3 others
No phase
6 of 15
2 open now
Registered
13th of 15
by date
Lead sponsor
2 of 15
Lacer S.A.

Among the 15 studies in Gingivitis with a site in Spain, this one is the 9th largest by enrollment of the 13 interventional ones that give a count, is one of 4 that started in 2026, is one of 6 with no phase, and was the 13th registered.

Gingivitis

636 studies on the registry are indexed under Gingivitis; 109 are open to participants now.

Browse Gingivitis studies →

Open to participants now

2 of the 15 studies in Gingivitis with a site in Spain are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 54 Gingivitis studies recruiting now, 16 (30%) set no upper age limit and 36 (67%) stop at 75 or younger; 11 take children under 18; 36 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Gingivitis with a site in Spain, or all of them as a file.
02

Study summary

The goal of this study is to learn if a mouthwash works to alleviate gingivitis in adults. It will also learn about the safety of the product. The main question it aims to answer is:

  • Does the mouthwash help to improve signs of gingivitis?

Participants will:

  • Use mouthwash daily for 4 weeks
  • Visit the clinic on the established days during 4 weeks for check-ups and evaluation
03

Conditions studied

  • Gingivitis

Browse trials for

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy male and female subjects (with no specific repartition)
  2. Subjects of Caucasian ethnicity
  3. Subjects aged between 18 and 65 years (extremes included)
  4. Subjects clinically showing moderate gums inflammation (gingivitis grade II, in particular all gingival scores for the mean should be between 1.75 and 2.3, according to Löe and Silness gingival scoring system), in particular:

    1. 20% of the subjects with localized gingivitis (10-30% of evaluated sites with bleeding)
    2. 80% of them with generalized gingivitis (>30% of evaluated sites with bleeding)
  5. Subjects with dental plaque (total plaque score at inclusion ≥2)
  6. Subjects registered with the national health service
  7. Subjects certifying the truthfulness of the personal data disclosed to the Principal Investigator or designated personnel
  8. Subjects able to understand the language used in the investigation centre and the information given by the Principal Investigator or designated personnel
  9. Subjects able to respect the instructions given by the Principal Investigator or designated personnel as well as able to respect the study constraints and specific requirements
  10. Subjects who commit not to change their daily routine or lifestyle during the study
  11. Subjects on stable pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) for at least one month without any changes expected or planned during the study
  12. Subjects informed about the test procedures who have signed a consent form and privacy agreement

Exclusion criteria

Exclusion Criteria:

  1. Subjects who do not meet the inclusion criteria
  2. Smokers subjects
  3. Subjects planning toothcare during the study period
  4. Subjects using dental apparatus or using dental prosthesis, with generalized tooth recession, with presence of caries, with dental abscess or signs of periodontitis (periodontal probing depth >3mm) or active periodontitis
  5. Subjects using other dental hygiene products than provided (e.g. dental floss, interdental brushes, mouthwash, etc) during the study period
  6. Subjects with any acute, chronic, or progressive disease or condition that may interfere with the study data or that the Principal Investigator considers dangerous to the subject or incompatible with the requirements of the study
  7. Subjects participating or planning to participate in other clinical trials
  8. Subjects who participated in a similar study without respecting an adequate (at least one month)
  9. Subjects that have intolerances or allergies to ingredients of the study product Page 8 of 28 Clinical Study Protocol: EC_0000149/2026 of 13/03/2026
  10. Subjects under pharmacological treatments that are considered incompatible with the study requirement by the Principal Investigator
  11. Subjects who are currently using products with the same activity as the study product, or who haven't observed an adequate washout period (at least one month)
  12. Subjects admitted to a health or social facility
  13. Subjects planning a hospitalization during the study
  14. Subjects not able to be contacted in case of emergency
  15. Subjects deprived of freedom by administrative or legal decision or under guardianship
  16. Subjects who have or have had a history of alcohol or drug addiction
  17. Subjects with eating disorders (i.e. bulimia, psychogenic eating disorders, etc.)
  18. Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of ).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Washout period

A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    mouthwash

    Mouthwash will be used 3 times a day after brushing during 4 weeks.

    Other: Mouthwash for delicate gums

Interventions

  • OtherMouthwash for delicate gums

    Mouthwash will be used 3 times a day after brushing during 4 weeks.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Gingival Index Score at 4 weeks

    The score is from 0 (normal gum) to 4 (severe inflammation, swelling, bleeding and presence of ulcers).

    Time frame: From enrolment to the end of use at 4 weeks.

07

Study locations

1 site
  • Clinica Dental Rob
    Badalona, Spain
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Only summary of the results to support the publication will be shared. No complete study documents will shared

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Jul 2026, 4 months.

Of 53 industry-sponsored interventional studies with no phase under Gingivitis, half reached primary completion within 2 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 5. This study's 4 months is above that.

Counting every sponsor, half of 260 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 16, 2026
First posted
Apr 27, 2026
StartActual
Mar 3, 2026
Primary completionActual
Jul 10, 2026
CompletionActual
Jul 10, 2026
Last update
Aug 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07551908
Lead sponsor
Lacer S.A.
Responsible party
Sponsor
First posted
Apr 27, 2026
Start date
Mar 3, 2026
Primary completion
Jul 10, 2026
Completion
Jul 10, 2026
Last update
Aug 26, 2026

Study contacts

Robas
principal investigator · Clinica Dental Rob

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion